A Study of Dopamine Type 2 (D2) Receptor Occupancy Following a Single Oral Dose of OROS Paliperidone
Status:
Completed
Trial end date:
2003-06-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to estimate the relationship of D2-receptor occupancy to
plasma concentration and to assess the safety of OROS paliperidone.
Phase:
Phase 1
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.